Active Ingredient(s):Lemborexant FDA Approved: * December 20, 2019 Pharm Company: *EISAI INC Category:Sleep Aid
Lemborexant, sold under the brand name Dayvigo, is an orexin antagonist medication which is used in the treatment of insomnia. It is indicated specifically for the treatment of insomnia characterized by difficulties with sleep onset and/or maintenance in adults. The medication is taken by mouth.
Side effects of lemborexant include somnolence, fatigue, headache, and abnormal dreams...
* May have multiple approval dates, manufacturers, or labelers. 2 Discussions